Targeting hormones could reduce risk of fatty liver disease

A deeper understanding of a gene that predisposes patients to fatty liver disease may open new avenues for treatment of the condition, according to Yale research published in Cellular and Molecular Gastroenterology and Hepatology.

Leave A Comment

Your email address will not be published. Required fields are marked *